Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-10-000363
Filing Date
2010-05-19
Accepted
2010-05-19 12:19:08
Documents
2
Group Members
ADAM STERNAM INVESTMENT PARTNERS, LLCBAM MANAGEMENT, LLCBAM OPPORTUNITY FUND SPV, LLCHAL MINTZMARK FRIEDMANROSS BERMAN

Document Format Files

Seq Description Document Type Size
1 oxigene_sch13ga2.htm SC 13G/A 174442
2 oxigene_sch13ga2ex1.htm EX-1 13117
  Complete submission text file 0000929638-10-000363.txt   189701
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Subject) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45691 | Film No.: 10844563
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005
Business Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005 646-307-4503
BAM Opportunity Fund, L.P. (Filed by) CIK: 0001433768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A